CTOs on the Move

Tunstall

www.tunstall.com

 
From its founding in 1777 as California`s first city, San José has been a leader driven by its spirit of innovation. Today, San José stands as the largest city in Northern California and the Capital of Silicon Valley—the world`s leading center of technology innovation. San José is the 10th largest in the U.S., and is committed to remaining a top-ranked place to do business, work, live, play and learn. San José is located in Santa Clara County at the southern edge of the San Francisco Bay, about 50 miles south of San Francisco, 390 miles north of Los Angeles. The ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.tunstall.com
  • 1672 Barrington Street Suite 300
    Halifax, NS CAN B3J 2A2
  • Phone: 902.423.2032

Executives

Name Title Contact Details
Gary Steen
Group Chief Technology Officer Profile

Similar Companies

SPARC

Cannabis dispensaries in San Francisco, Santa Rosa, and Sebastopol, SPARC offers same-day cannabis delivery in San Francisco and Sonoma County.

Herewith

Herewith is a company that provides a platform for families to find and hire in-home senior care professionals. Their platform offers personalized caregiver matching, innovative care coordination services, and opt-in safety alerts.

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

SecureAlert

SecureAlert, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. SecureAlert, Inc is based in Sandy, UT. You can find more information on SecureAlert, Inc at www.remotemdx.com